{
    "eid": "2-s2.0-85119907690",
    "title": "Limited protection of inactivated SARS-CoV-2 vaccine against wild-type strain and variants of concern",
    "cover-date": "2021-12-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Epidemiology",
            "@code": "2713",
            "@abbrev": "MEDI"
        },
        {
            "@_fa": "true",
            "$": "Microbiology (medical)",
            "@code": "2726",
            "@abbrev": "MEDI"
        },
        {
            "@_fa": "true",
            "$": "Infectious Diseases",
            "@code": "2725",
            "@abbrev": "MEDI"
        }
    ],
    "keywords": [],
    "authors": [
        "Taweewun Hunsawong",
        "Stefan Fernandez",
        "Rome Buathong",
        "Naretrit Khadthasrima",
        "Kamonthip Rungrojchareonkit",
        "Jindarat Lohachanakul",
        "Rungarun Suthangkornkul",
        "Kedsara Tayong",
        "Angkana T. Huang",
        "Chonticha Klungthong",
        "Piyawan Chinnawirotpisan",
        "Yongyuth Poolpanichupatam",
        "Anthony R. Jones",
        "Eric D. Lombardini",
        "Supaporn Wacharapluesadee",
        "Opass Putcharoen"
    ],
    "citedby-count": 10,
    "ref-count": 5,
    "ref-list": [
        "Reduced sensitivity of SARS-CoV-2 variant Delta to antibody neutralization",
        "Double-blind, randomized, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of treating healthcare professionals with the adsorbed COVID-19 (inactivated) vaccine manufactured by Sinovac-PROFISCOV: a structured summary of a study protocol for a randomised controlled trial",
        "Effectiveness of an inactivated SARS-CoV-2 vaccine in Chile",
        "Susceptibility of circulating SARS-CoV-2 variants to neutralization",
        "Effect of 2 inactivated SARS-CoV-2 vaccines on symptomatic COVID-19 infection in adults: a randomized clinical trial"
    ],
    "affiliation": [
        {
            "affiliation-city": "Nontaburi",
            "@id": "60015728",
            "affilname": "Thailand Ministry of Public Health",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60015728",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60031780",
            "affilname": "Thai Red Cross Agency",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60031780",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60028190",
            "affilname": "Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60016185",
            "affilname": "Armed Forces Research Institute of Medical Sciences, Thailand",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60016185",
            "affiliation-country": "Thailand"
        }
    ],
    "funding": [
        "National Institutes of Health",
        "National Institute of Allergy and Infectious Diseases",
        "National Research Council of Thailand"
    ]
}